QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CRMD

QT76CorMedix Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
8.67
+0.00%
OverviewShort InterestFilings
CRMDQT76CorMedix Inc.·NASDAQ
OverviewShort InterestFilings
8.67+0.00%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E3.81EPS (ttm)
2.11
Insider Own12.91%
Shs Outstand78.45M
Perf Week-3.24%
Market Cap680.18MForward P/E100.81EPS next Y0.09Insider Trans0.13%Shs Float-Perf Month10.87%
Enterprise Value646.98MPEG0.00EPS next Q-Inst Own-Short Float-Perf Quarter37.62%
Income178.61MP/S1.70EPS this Y-76.30%Inst Trans-Short Ratio-Perf Half Y-24.21%
Sales400.06MP/B1.58EPS next Y-82.80%ROA22.19%Short Interest-Perf YTD-25.45%
Book/sh5.57P/C3.49EPS next 5Y27.95%ROE50.38%52W High17.43 -50.26%Perf Year-37.80%
Cash/sh2.27P/FCF3.46EPS past 3/5Y-ROIC27.59%52W Low6.13 41.44%Perf 3Y-
Dividend Est.-EV/EBITDA3.04Sales past 3/5Y-Gross Margin85.83%Volatility2.09% 2.39%Perf 5Y-
Dividend TTM-EV/Sales1.62EPS Y/Y TTM-Oper. Margin48.41%ATR (14)0.31Perf 10Y-
Dividend Ex-Date-Quick Ratio2.74Sales Y/Y TTM830.23%Profit Margin45.25%RSI (14)59.28Recom2.00
Dividend Gr. 3/5Y-Current Ratio2.98EPS Q/Q-SMA202.22%Beta1.37Target Price14.00
Payout0.00%Debt/Eq0.33Sales Q/Q225.64%SMA509.09%Rel Volume2.04Prev Close8.67
Employees64LT Debt/Eq0.37Earnings-SMA200-5.40%Avg Volume1.23MPrice8.67
IPO DateMay 13, 2010Option/ShortYes / YesEPS/Sales Surpr.-Net Debt/EBITDA-0.16Volume2,511,951Change0.00%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-28-26ReiteratedRBC CapitalOutperform$13 → $14
Mar-06-26ReiteratedLeerink Partners$13
Jan-23-26ReiteratedH.C. Wainwright$18 → $13
Jan-21-26ReiteratedRBC CapitalOutperform$22 → $13
Jan-08-26ReiteratedTruist Financial$20 → $16
Oct-21-25ReiteratedRBC CapitalOutperform$9.00 → $22
Oct-20-25UpgradeD. Boral CapitalHold → Buy
Aug-08-25ReiteratedH.C. Wainwright$20 → $17
Jun-30-25DowngradeD. Boral CapitalBuy → Hold
Mar-13-24ReiteratedRBC CapitalOutperform$9.00
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue40031243
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A56363
Gross Profit34327640
Selling, General and Administrative Excl. Other1273059
Research and Development23194
Other Operating Expense-1770
Operating Income194150-22
Interest Expense330
Unusual Expense
———
Non-Operating Income (Expense)6-3-3
Net Income Before Taxes185150-19
Income Taxes4-13-1
Consolidated Net Income182163-18
Net Income From Continuing Operations182163-18
Net Income182163-18
EPS (Recurring)2.382.25-0.30
EPS (Basic, Before Extraordinaries)2.382.25-0.30
EPS (Diluted)2.112.04-0.30
EBITDA213168-19
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio4.115.70—
Price To Sales Ratio1.732.68—
Gross Margin85.7588.4693.02
Operating Margin48.5048.08-51.16
Net Margin45.5052.24-41.86
Shares Outstanding807259
Market Capitalization694837—
Operating Lease Expense
———
Insider Trading Volume
$9.27$8.56$7.84$7.13$6.42● Close Price0.00M0.54M1.08M1.62M2.16MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Dillione JanetDirectorJan 21 '26Sale6.8810,00068,80038,473Jan 22 12:00 AM
Todisco JosephChief Executive OfficerJan 16 '26Option Exercise3.3859,170199,994521,664Jan 20 12:00 AM
Lefkowitz Steven WDirectorJan 12 '26Option Exercise5.6330,000168,90095,498Jan 14 12:00 AM
DUNTON ALAN WDirectorDec 30 '25Option Exercise4.0340,000161,20060,250Jan 02 12:00 AM
DUNTON ALAN WDirectorDec 30 '25Sale13.0020,000260,00040,250Jan 02 12:00 AM
Todisco JosephChief Executive OfficerDec 18 '25Option Exercise4.4360,000265,800539,496Dec 19 12:00 AM
Todisco JosephChief Executive OfficerDec 18 '25Sale12.0030,000360,000509,496Dec 19 12:00 AM
Dillione JanetDirectorDec 09 '25Option Exercise7.8268,000531,80082,473Dec 11 12:00 AM
Dillione JanetDirectorDec 09 '25Sale12.0034,000408,00048,473Dec 11 12:00 AM
Lefkowitz Steven WDirectorDec 09 '25Sale11.8840,000475,20080,498Dec 10 12:00 AM
Dillione JanetDirectorDec 02 '25Option Exercise3.9693,314369,60495,130Dec 04 12:00 AM
Dillione JanetDirectorDec 02 '25Sale10.0046,657466,57048,473Dec 04 12:00 AM
Dillione JanetDirectorNov 24 '25Option Exercise3.6452,686191,89674,816Nov 26 12:00 AM
Dillione JanetDirectorNov 24 '25Sale9.9326,343261,58648,473Nov 26 12:00 AM
Dillione JanetDirectorNov 14 '25Sale11.4230,000342,60048,473Nov 18 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR